Wang J H, Nichogiannopoulou A, Wu L, Sun L, Sharpe A H, Bigby M, Georgopoulos K
Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, USA.
Immunity. 1996 Dec;5(6):537-49. doi: 10.1016/s1074-7613(00)80269-1.
Mice homozygous for an Ikaros null mutation display distinct defects in the development of fetal and adult lymphocytes. Fetal T lymphocytes, and fetal and adult B lymphocytes and their earliest progenitors are absent. Postnatally, hematopoietic stem cells give rise to thymocyte precursors that undergo aberrant differentiation into the CD4 lineage and clonal expansion. The lack of NK cells and some gamma delta T cell subsets and a large reduction in thymic dendritic APCs suggest that Ikaros is essential for establishing early branch points in the postnatal T cell pathway. The lymphoid defects detected in Ikaros null mice reveal critical molecular differences between fetal and postnatal hematopoietic progenitors that dictate their ability to give rise to T cells. These studies also establish Ikaros as a tumor suppressor gene acting during thymocyte differentiation. Phenotypic comparison of this null mutation with a severe dominant-negative Ikaros mutation identifies molecular redundancy in the postnatal hemolymphoid system.
Ikaros基因无效突变的纯合小鼠在胎儿和成年淋巴细胞发育过程中表现出明显缺陷。胎儿T淋巴细胞、胎儿和成年B淋巴细胞及其最早的祖细胞缺失。出生后,造血干细胞产生胸腺细胞前体,这些前体经历异常分化进入CD4谱系并发生克隆扩增。缺乏自然杀伤细胞和一些γδT细胞亚群以及胸腺树突状抗原呈递细胞大幅减少,表明Ikaros对于在出生后T细胞途径中建立早期分支点至关重要。在Ikaros基因无效小鼠中检测到的淋巴缺陷揭示了胎儿和出生后造血祖细胞之间的关键分子差异,这些差异决定了它们产生T细胞的能力。这些研究还确定Ikaros是一种在胸腺细胞分化过程中起作用的肿瘤抑制基因。将这种无效突变与严重的显性负性Ikaros突变进行表型比较,确定了出生后血液淋巴系统中的分子冗余。